Technology

Where is the Potential for Improving Wound Closure and Management?

2 Mins read

A driving force in medtech development is one that creates incentive for improving healthcare in ways that can be demonstrated, or at least marketed.  Put simply, if a manufacturer can produce a technology that achieves even a marginally better healthcare outcome, especially if it can be delivered at the same or, better yet, marginally lower cost, then that is an improvement in healthcare.

A driving force in medtech development is one that creates incentive for improving healthcare in ways that can be demonstrated, or at least marketed.  Put simply, if a manufacturer can produce a technology that achieves even a marginally better healthcare outcome, especially if it can be delivered at the same or, better yet, marginally lower cost, then that is an improvement in healthcare.

In the field of wound care, there is a very clear understanding that if a technology can reduce the time, complications and therefore cost of healing a wound, then such a technology should be pursued.  To make this even more precise, if a technology can simply reduce the cost of healing a wound, with considerations of cost including that time is inevitably of the essence, then that technology has upside potential.

A useful starting point for determining which wound closure and management products have such potential, whether those products are direct or adjunctive surgical closure and securement products, is to consider the different wound types and their different potential to be targeted for improved outcomes, cost or both.

Surgical wounds are usually appropriate for treatment with adjunctive surgical closure and securement products because they are created under clean conditions, the usual acute healing cascade of events begins immediately and control of the bleeding and closure process can lead to accelerated healing, improved prognosis, and enhanced aesthetic effects such as reduced scarring.

Prevalence, Healing Time and Growth of Wound Types, 2009

Source: MedMarket Diligence, LLC, Report #S180, “Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion, 2010-2015.”

Surgical wounds offer the potential for devices to ensure hemostasis, prevent internal adhesions and anastomoses, soft tissue securement, and closure of the skin. Traumatic wounds also offer potential for skin closure products and for hemostats, and adhesion prevention during post- trauma surgery. New wound-covering sealant products may also offer potential for treatment of cuts, grazes, and burns.

Chronic wounds are generally not amenable for treatment by adhesives, sealants and hemostats unless the wound has been debrided to a sterile bleeding surface (in which case it becomes like a surgical wound), or the product offers some stimulant activity; many hemostats exhibit some inflammatory and cytokinetic activity, which has been associated with accelerated healing.

To help determine how these applications for closure and securement products may translate into market potential, it is relevant to note the incidence of the different types of wounds; the table provided in this post gives this data. The potential contribution of newly developed products to the management of these different wounds is what is driving development of novel wound closure and management technologies.

     

Avatar
183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Articles
Related posts
DiagnosticsTechnology

New Medical Laboratories Are the Key to Diagnostics Research

3 Mins read
The development of the COVID-19 vaccine was a miracle in medical research. It shows the incredible importance of medical innovation in the…
DiagnosticsTechnology

How Rapid Blood Testing Solves Blood Lab Wait Time Issues

3 Mins read
In early November 2020, Steven Hill* experienced a concerning and prolonged bout of nausea, weakness, and a host of other symptoms that…
Health careMedical DevicesTechnology

Can Medical Devices Help Reduce the Cost of Healthcare?

8 Mins read
Healthcare costs are on the rise; according to CNN Money, a 2016 report reveals the huge cost gap between the early 2000s…